Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers-Reference-Cited by-同舟云学术

Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers

Published:2022-09-02 Issue:35 Volume:101 Page:e30471
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Katoh Yuki,Hara Hiroyuki,Harada Tomonori,Hirai Shuichi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference37 articles.

1. Estimated projection of US cancer incidence and death to 2040;Rahib;JAMA Netw Open,2021

2. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases;Yamada;Arch Dermatol,1992

3. Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years’ experience;Wakamatsu;Melanoma Res,2002

4. Significance of 5-S-cysteinyldopa as a marker for melanoma;Wakamatsu;Int J Mol Sci,2020

5. Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma;Bánfalvi;Pathol Oncol Res,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy;Journal of Experimental & Clinical Cancer Research;2024-08-15

2. Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis;Carcinogenesis;2023-10-16

3. Determination of the Degradation Products of Pheomelanin as Potential Biomarker for Early-Stage Melanoma by Gas Chromatography-Mass Spectrometry (GC-MS);Analytical Letters;2023-08-28